1-4 of 4
Kailee Tanaka
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA (ctDNA) Enables Superior and Universal Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) Highly Predictive of Relapse Free and Overall Survival

Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Sky Kim, Kailee Tanaka, Sanjeeth Rajaram, Mia Carleton, Raymond Yin, Matthew Alkaitis, Matthew Schwede, Brian J. Sworder, Michael S. Khodadoust, Ravi Majeti, David Kurtz, Tian Y Zhang
Journal: Blood
Blood (2024) 144 (Supplement 1): 2955.
https://doi.org/10.1182/blood-2024-201701
Published: 2024
Journal Articles

Immunosuppression in Isocitrate Dehydrogenase Mutated Acute Myeloid Leukemia

Jesse W. Tai, Guan Li, Kailee Tanaka, Jayakrishnan Gopakumar, Crystal Zhou, Miles Hamilton Linde, Alejandro Villar-Prados, Athreya S Rangavajhula, Aaron C Trotman-Grant, Niklas Landberg, Amy C Fan, Gabriel Mannis, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1335.
https://doi.org/10.1182/blood-2023-187981
Published: 2023
Journal Articles

Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)

Ruwan Gunaratne, Crystal Zhou, Jesse W. Tai, Matthew Schwede, Kailee Tanaka, Matthew Alkaitis, Raymond Yin, Brian J. Sworder, Gabriel Mannis, Ravindra Majeti, Michael S. Khodadoust, David M. Kurtz, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4307.
https://doi.org/10.1182/blood-2023-181459
Published: 2023
Journal Articles

Phase 1b/2 Trial of Enasidenib in Lower-Risk MDS and Nonproliferative CMML without Isocitrate Dehydrogenase Type 2 Mutations

Eric Kuo, Veronica Santiago, Kailee Tanaka, Vikram Puram, Crystal Zhou, Jesse W. Tai, Gabriel Mannis, Ravindra Majeti, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1879.
https://doi.org/10.1182/blood-2023-187644
Published: 2023